# Angiogenic Imaging in Pulmonary Arterial Hypertension

> **NCT03166306** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 5 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Exercise Associated Pulmonary Arterial Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** PET-CT Imaging with [89Zr]-bevacizumab

## Key facts

- **NCT ID:** NCT03166306
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166306, "Angiogenic Imaging in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03166306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*